Literature DB >> 25399540

Immune mediated disorders in women with a fragile X expansion and FXTAS.

Isha Jalnapurkar1, Nuva Rafika, Flora Tassone, Randi Hagerman.   

Abstract

Premutation alleles in fragile X mental retardation 1 (FMR1) can cause the late-onset neurodegenerative disorder, fragile X-associated tremor ataxia syndrome (FXTAS) and/or the fragile X-associated primary ovarian insufficiency in approximately 20% of heterozygotes. Heterozygotes of the FMR1 premutation have a higher incidence of immune mediated disorders such as autoimmune thyroid disorder, especially when accompanied by FXTAS motor signs. We describe the time course of symptoms of immune mediated disorders and the subsequent development of FXTAS in four women with an FMR1 CGG expansion, including three with the premutation and one with a gray zone expansion. These patients developed an immune mediated disorder followed by neurological symptoms that become consistent with FXTAS. In all patients we observed a pattern involving an initial appearance of disease symptoms-often after a period of heightened stress (depression, anxiety, divorce, general surgery) followed by the onset of tremor and/or ataxia. Immune mediated diseases are associated with the manifestations of FXTAS temporally, although further studies are needed to clarify this association. If a cause and effect relationship can be established, treatment of pre-existing immune mediated disorders may benefit patients with pathogenic FMR1 mutations.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CGG repeat; FMR1 gene; FXTAS; RNA toxicity; autoimmune disease; genetic counseling; premutation

Mesh:

Substances:

Year:  2014        PMID: 25399540      PMCID: PMC4275322          DOI: 10.1002/ajmg.a.36748

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  48 in total

1.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

2.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

3.  Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study.

Authors:  Elan Louis; Carol Moskowitz; Michael Friez; Maria Amaya; Jean Paul G Vonsattel
Journal:  Mov Disord       Date:  2006-03       Impact factor: 10.338

Review 4.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

5.  Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.

Authors:  Claudia M Greco; Kultida Soontrapornchai; Juthamas Wirojanan; John E Gould; Paul J Hagerman; Randi J Hagerman
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

6.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

7.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

8.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

9.  Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; E Severijnen; F H de Jong; D Hessl; R J Hagerman; B A Oostra; R Willemsen
Journal:  Psychoneuroendocrinology       Date:  2008-05-12       Impact factor: 4.905

Review 10.  Advances in microRNAs: implications for immunity and inflammatory diseases.

Authors:  E Sonkoly; A Pivarcsi
Journal:  J Cell Mol Med       Date:  2009-01       Impact factor: 5.310

View more
  14 in total

Review 1.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

Review 2.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

3.  A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population.

Authors:  L Lorefice; S Tranquilli; G Fenu; M R Murru; J Frau; M Rolesu; G C Coghe; F Marrosu; M G Marrosu; E Cocco
Journal:  Neurol Sci       Date:  2015-07-21       Impact factor: 3.307

Review 4.  Beyond Moco Biosynthesis-Moonlighting Roles of MoaE and MOCS2.

Authors:  Tamaki Suganuma
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

Review 5.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

6.  Aging in Fragile X Premutation Carriers.

Authors:  Reymundo Lozano; Naomi Saito; Dallas Reed; Marwa Eldeeb; Andrea Schneider; David Hessl; Flora Tassone; Laurel Beckett; Randi Hagerman
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

7.  Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.

Authors:  Sarah M Debrey; Maureen A Leehey; Olga Klepitskaya; Christopher M Filley; Raj C Shah; Benzi Kluger; Elizabeth Berry-Kravis; Elaine Spector; Flora Tassone; Deborah A Hall
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

8.  Women with Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Andrea Schneider; Scott Summers; Flora Tassone; Andreea Seritan; David Hessl; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord Clin Pract       Date:  2020-09-23

9.  Stress and genetics influence hair cortisol in FMR1 premutation carrier mothers of children with fragile X syndrome.

Authors:  Jinkuk Hong; Amita Kapoor; Leann Smith DaWalt; Nell Maltman; Bryan Kim; Elizabeth M Berry-Kravis; David Almeida; Christopher Coe; Marsha Mailick
Journal:  Psychoneuroendocrinology       Date:  2021-05-13       Impact factor: 4.693

Review 10.  Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.

Authors:  Indhu-Shree Rajan-Babu; Hai-Yang Law; Chui-Sheun Yoon; Caroline G Lee; Samuel S Chong
Journal:  Expert Rev Mol Med       Date:  2015-05-04       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.